银华中证创新药产业ETF发起式联接C (012782.jj ) CS创新药 (半年) 银华基金管理股份有限公司申 | 基金经理王帅基金类型指数型基金(ETF,联接型)成立日期2021-12-30总资产规模 (2025-12-31) 基金净值0.6980元 (2026-04-17) 管理费用率0.50%管托费用率0.05% (2025-12-19) 成立以来分红再投入年化收益率-8.02% (5541 / 5786) |
| 相关基金: | 主从基金: 银华中证创新药产业ETF发起式联接A目标基金: 创新药 |
| 备注 (0): | 双击编辑备注 |
银华中证创新药产业ETF发起式联接C(012782) - 历史月度涨跌幅
| 年 | 基金名称 | 1月 | 2月 | 3月 | 4月 | 5月 | 6月 | 7月 | 8月 | 9月 | 10月 | 11月 | 12月 | 年度涨跌幅 | 年度超额收益率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 银华中证创新药产业ETF发起式联接C | 0.45% | -1.75% | -0.10% | 3.09% | -- | -- | -- | -- | -- | -- | -- | -- | 1.63% | -0.21% |
| CS创新药 | 0.46% | -1.82% | -0.07% | 3.33% | -- | -- | -- | -- | -- | -- | -- | -- | 1.84% | ||
| 2025 | 银华中证创新药产业ETF发起式联接C | -2.61% | 5.45% | 3.21% | -0.62% | 7.40% | -0.05% | 15.82% | 2.78% | 1.75% | -4.68% | -4.51% | -4.78% | 18.70% | -0.64% |
| CS创新药 | -2.75% | 5.67% | 3.38% | -0.84% | 7.71% | -0.22% | 16.85% | 2.99% | 1.84% | -5.03% | -4.69% | -4.98% | 19.34% | ||
| 2024 | 银华中证创新药产业ETF发起式联接C | -21.28% | 12.77% | -3.96% | 0.75% | -5.06% | -7.27% | 3.80% | -3.23% | 21.45% | -4.85% | 2.90% | -5.04% | -14.22% | 2.30% |
| CS创新药 | -22.60% | 13.91% | -4.37% | 0.87% | -5.82% | -8.03% | 3.91% | -3.59% | 23.05% | -5.49% | 3.11% | -5.64% | -16.51% | ||
| 2023 | 银华中证创新药产业ETF发起式联接C | 7.14% | -2.58% | -6.05% | -0.76% | -4.63% | -5.59% | 2.47% | -4.42% | 5.22% | 3.58% | 0.66% | -6.19% | -11.68% | 0.23% |
| CS创新药 | 7.74% | -2.72% | -6.31% | -0.10% | -5.16% | -5.99% | 2.25% | -4.88% | 5.62% | 3.77% | 0.85% | -6.31% | -11.91% | ||
| 2022 | 银华中证创新药产业ETF发起式联接C | -15.27% | 3.02% | 3.17% | -13.98% | -0.38% | 12.42% | -8.40% | -3.10% | -9.03% | 5.51% | 4.20% | -0.61% | -23.45% | 2.28% |
| CS创新药 | -16.93% | 3.32% | 3.53% | -15.03% | -0.53% | 13.49% | -9.47% | -3.22% | -9.93% | 5.95% | 4.80% | -0.56% | -25.74% | ||
| 2021 | 银华中证创新药产业ETF发起式联接C | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -0.23% | -0.23% | 10.38% |
| CS创新药 | 1.53% | -1.81% | -1.70% | 13.41% | 0.90% | -1.38% | -7.62% | -7.98% | 4.11% | -4.53% | 2.26% | -6.44% | -10.61% | ||
| 2020 | 银华中证创新药产业ETF发起式联接C | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| CS创新药 | 5.10% | 2.60% | -1.68% | 8.67% | 5.02% | 17.80% | 21.02% | -6.19% | -10.14% | 3.35% | -8.84% | 13.24% | 55.14% | ||
| 2019 | 银华中证创新药产业ETF发起式联接C | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| CS创新药 | -- | -- | -- | -0.87% | -7.68% | 4.22% | 2.58% | 8.55% | -2.46% | 6.32% | -2.07% | 3.13% | 11.24% |